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Background: In the setting of PCI for ULMCA disease, left anterior descending
artery (LAD) is generally considered the main branch. However, whether the choice of
LAD over LCX as main branch has a signiﬁcant impact on clinical outcomes has not
yet been ascertained.
Methods: Between April 2002 and April 2006, a total of 2775 patients were included
in the DELTA registry: 1,874 were treated with PCI versus 901 with CABG. Of the
percutaneous group, we selected only those patients who had distal left main disease
and complete information about stenting technique. After 1:1 propensity-score
matching was performed, matched pairs of patients were selected and analyzed.
Results: In total 276 patients were included in the analysis: in 138 cases the selected
main branch was the LAD (LM-LAD) and in 138 cases was the LCX (LM-LCX).
Clinical, angiographic and procedural characteristics in the matched groups were
similar. Mean EuroSCORE and SyntaxSCORE in the LM-LAD and LM-LCX groups
were 5.33.2 vs 5.53.6 (p¼ 0.34) and 29.710.8 vs 28.910 (p¼ 0.56). Two stent
strategy was used in 57.2% vs. 53.6% of cases (p¼0.56). Incidence of adverse events
at follow-up (median: 1098 days; IQR 396-1478) are reported in Table 1. MACCE-
free survival rate in the LM-LAD and LM-LCX groups at1478 days was 60.4 % vs
51.2% (p¼0.012). When stratiﬁed by stent strategy (1 vs 2 stent technique), the
signiﬁcant advantage of the LM-LAD subgroup in terms of death, TLR, TVR and
MACCE was conﬁrmed in patients who were treated with a 2 stent technique while no
difference between groups was found when a single stent strategy was considered.LM-LAD LM-LCX
(n=138) (n=138)
N,
meanDS %
N,
meanDS %
P
value
Events at FU [median:
1098days (IQR 396-1478)]
Death 19 13,8 34 24,6 0,03
MI 4 2,9 4 2,9 1
CVA 2 1,4 4 2,9 0,68
TLR 17 12,3 30 21,7 0,05
TVR 22 15,9 38 27,5 0,03
PCI on other vessels 21 15,2 35 25,4 0,05
CABG 1 0,7 6 4,3 0,12
MACCE 41 29,7 68 49,3 <0,01
Deﬁnite/probable ST 1 0,7 3 2,2 0,62Conclusions: In this series of matched patients with ULMCA disease, the choice of
LAD over LCX as main branch was correlated with a signiﬁcantly lower incidence of
death, TLR, TVR and MACCE at long term FU. This advantage was substantial when
a two stent strategy was considered.B122 JACC Vol 62/18/Suppl B j October 27–November 1, 2TCT-389
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Background: Triple kissing balloon technique (triple-KBT) is a promising technique
to treat the left main (LM) trifurcation lesions with both single- and two-stent tech-
niques using drug-eluting stent (DES). However, the difference in clinical and
angiographic outcomes after DES implantation with triple-KBT between single- and
two-stent techniques was unknown.
Methods: From April 2005 to October 2012, 72 patients underwent DES implantation
with triple-KBT for LM trifurcation disease. We compared the clinical and angio-
graphic outcomes between single- (45 patients) and two-stent groups (27 patients).
Clinical outcomes were evaluated by all-cause death and target lesion revasculariza-
tion (TLR). Follow-up angiography was scheduled at 8 months after procedure.
Results: The angiographic success rate was 100%, and in-hospital death and coronary
artery bypass grafting were nothing. Procedural and angiographic follow-up data are
shown in the table. The two-stent group had more severe stenosis of side branches
than the single-stent group. The restenosis rate was similar between the 2 groups. The
median clinical follow-up duration was 797 days (interquartile range 595-977 days).
The incidence of TLR at 1 year was signiﬁcantly lower in the single-stent group than
in the two-stent group (4.5% vs. 32.3%, p¼0.002), and the incidence of TLR was
nothing since 1 year after procedure in both 2 groups.Conclusions: Triple-KBT after DES implantation was a safe and feasible technique
for LM trifurcation disease. Single-stent technique with triple-KBT was associated
with more favorable clinical outcomes compared with two-stent technique.
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Background: The percutaneous treatment of coronary bifurcation lesions with stent
implantation is associated with increased adverse clinical events and inferior angio-
graphic outcomes, when compared with mid-vessel lesions. The Axxess stent is
a dedicated, self-expanding, drug-eluting (Biolimus A9) bifurcation stent. The aim of
the present registry is to evaluate the feasibility in terms of procedural technique and
success, the efﬁcacy in terms of MACCE (cardiac death, Q-wave-MI, non Q-wave-
MI, TVR,TLR and stroke) and the safety in terms of stent thrombosis occurrence at 30
days, 6 and 12 months follow-up of a new bifurcation dedicated self-expandable
biodegradable polymer BES.
Methods: All consecutive patients referred to our cath-lab with de novo bifurcation
lesions, in which we implanted bifurcation dedicated self-expandable biodegradable
polymer stent, were included in our study. The choice of this stent has been left to the
operator's discretion considering the coronary anatomy and lesions characteristics. The
mean clinical follow-up was 3.9 months.
Results: 59 pts were treated with 60 Axxess stents. True bifurcations were 69.4%
according to the Medina classiﬁcation. The mean angle was 52.910.7. Pre-
dilatation was performed in 98.3% (89.8% with kissing balloon and 11.8% with
rotablator) and postdilatation with kissing balloon in 55.9%. Additional stenting was
implanted on PV distally to AXXESS in 52.5% pts; 30.5% in SB and 16.9% in both
branches. The placement was scored as optimal in 81.3% . Procedural angio success
was 100%. RVD was 3.10.26 mm, pre-procedure MLD was 0.510.39 mm, ﬁnal in
Axxess MLD was 3.120.28 mm. 100% of patients received a clinical follow-up. The
cumulative 30-days (100% pts) MACCE rate was 3.3% (1.6% non–Q-wave MI, 1.6%
Q-wave MI, 1.6% TVR, 1.6% TLR) and one acute ST. At 6 (32.2%) and 12 months
(27.1%) cumulative MACCE rate was 13.5% (1.6% non–Q-wave MI, 3.3% Q-wave
MI, 5% TVR, 3.3% TLR and 3.3% STROKE). No sub-acute and LST were found.013 j TCT Abstracts/POSTER/Bifurcation and Left Main Interventions
Hazard ratio (95% conﬁdence interval),
EES vs SES P-value
MACE
Intervention strategy
2-stent technique 0.23 (0.07 – 0.74) 0.013
1-stent technique 1.30 (0.69 – 2.48) 0.42
LM bifurcation
Yes 0.45 (0.19 – 1.06) 0.067
No 1.04 (0.51 – 2.11) 0.918
TVR
Intervention strategy
2-stent technique 0.25 (0.08 – 0.80) 0.019
1-stent technique 1.15 (0.56 – 2.36) 0.703
LM bifurcation
Yes 0.33 (0.12 – 0.93) 0.036
No 1.03 (0.49 – 2.18) 0.934
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SConclusions: This prospective multicenter study conﬁrms the safety and performance
of the Axxess stent in bifurcation lesions.The low rate of events shows that the Axxess
dedicated stent is a good choice in treating bifurcation lesions.
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Background: Side branch (SB) occlusion is a serious complication during percuta-
neous coronary intervention (PCI) for bifurcation lesions. This study sought to
investigate the predictors and outcomes of SB occlusion after main vessel (MV)
stenting in coronary bifurcation lesions.
Methods: Consecutive patients undergoing PCI using drug-eluting stents for bifur-
cation lesions with SB 2.3 mm were enrolled. We selected patients treated with 1-
stent technique or MV stenting ﬁrst strategy. SB occlusion after MV stenting was
deﬁned as Thrombolysis in Myocardial Infarction ﬂow grade <3.
Results: SB occlusion occurred in 187 (8.4%) of 2227 bifurcation lesions. In multi-
variate analysis, independent predictors of SB occlusion were preprocedural percent
diameter stenosis of the SB 50% (odds ratio [OR] 2.34; 95% conﬁdence interval
[CI] 1.59-3.43; p<0.001) and the proximal MV 50% (OR 2.34; 95% CI 1.57-3.50;
p<0.001), SB lesion length (OR 1.03; 95% CI 1.003-1.06; p¼0.03), and acute
coronary syndrome (OR 1.53; 95% CI 1.06-2.19; p¼0.02). Of 187 occluded SBs, ﬂow
was restored spontaneously in 26 (13.9%) and by SB intervention in 103 (55.1%), but
not in 58 (31.0%). Jailed wire in the SB was associated with ﬂow recovery (74.8%
versus 57.8%, p¼0.02). Cardiac death or myocardial infarction occurred more
frequently in patients with SB occlusion than those without SB occlusion (adjusted
hazard ratio 2.34; 95% CI 1.15-4.77; p¼0.02).
Conclusions: Angiographic ﬁndings of the SB, proximal MV stenosis, and clinical
presentation are predictive of SB occlusion after MV stenting. Occlusion of sizable SB
is associated with adverse clinical outcomes.
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Background: Treatment of coronary bifurcation lesions represents a challenging area
in interventional cardiology. When compared with nonbifurcation interventions,
bifurcation interventions have a lower rate of procedural success, higher procedural
costs, longer hospitalization, and a higher rate of clinical and angiographic restenosis.
A few small scale studies have reported promising immediate and mid-term results of
drug-coated balloon (DCB) compared to non-coated balloon or a mixed strategy of
DCB and bare metal stent in bifurcation lesions. We analyzed and compared the
safety, focused on the rates of late coronary thrombosis (LT), and the clinical follow-
up after DCB in bifurcation lesions without additional stenting - the so called “Drug-
eluting balloon (DEB) only strategy” in a clinical setting.
Methods: A retrospective review was done of 85 consecutive patients who underwent
percutaneous coronary intervention procedure in de-novo lesions with the paclitaxel
eluting balloon SeQuent Please at a high-volume Heart Center in Potsdam. DCB
was used for the treatment of bifurcation lesions in 38 patients in 38 interventions.
Dual antiplatelet therapy with aspirin and clopidogrel/prasugrel (DAPT) was recom-
mended after DCB angioplasty.
Results: Most represented Medina type was 0/0/1 (36.8%). The procedure was
successful in all patients. Additional stenting of the main branch was needed in 3
(7.9%) interventions. No MACE (cardiac death, myocardial infarction, target lesion
revascularization) occurred up to 30 days. Within 12 months after intervention none of
the patients (0%) patients needed a target lesion revascularization or had suffered from
coronary thrombosis. Duration of DAPT was 4.2  3.8 months.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: The DEB only strategy is a treatment option for patients with bifur-
cation lesions and offers favorable results regarding procedural success, a low risk of
coronary late thrombosis and a low rate of target lesion revascularization.
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Background: Although drug-eluting stents (DES) have markedly broadened indica-
tions for percutaneous coronary intervention (PCI), bifurcation lesion still remains
a challenge. We sought to evaluate the efﬁcacy and safety of everolimus-eluting stent
(EES) for the treatment of bifurcation coronary lesions in comparison to SES (siro-
limus-eluting stent).
Methods: We analyzed the large-scale Korean multi-center registry for bifurcated
coronary lesions, COBIS (Coronary Bifurcation Stenting) II registry. In this registry,
1,762 patients treated with EES (n ¼ 348) or SES (n ¼ 1,414) were enrolled.
Primary outcome was major adverse cardiac events (MACE), deﬁned as a composite
of cardiac death, nonfatal myocardial infarction, and target vessel revascularization
(TVR).
Results: In all bifurcation lesions, EES was comparable to SES regarding MACE,
cardiac death, and TVR rates in the overall population as well as in the 1:3 propensity
score-matched one within 2-year follow-up. However, in speciﬁc subpopulation such
as patients with left main (LM) bifurcation lesions or those treated with 2-stent
technique (table), EES was superior to SES in terms of TVR and MACE rate in the
matched population. The interaction between the type of drug eluting stents and the
intervention strategy was signiﬁcant for both MACE (P ¼ 0.011) and TVR (P ¼
0.030). There was no difference in clinical outcomes between the 2 DESs in non-LM
bifurcation lesions or in patients treated with 1-stent technique.Conclusions: In this large-scale Korean multi-center registry for bifurcated coronary
lesions, EES was superior to SES in patients undergoing complex bifurcation inter-
vention, such as LM bifurcation or two-stent technique PCI.
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Background: It has been unknown whether intentional effort to minimize residual
stenosis of side branch (SB) during percutaneous coronary intervention (PCI) for
coronary bifurcation lesion will improve long-term clinical outcomes or not.acts/POSTER/Bifurcation and Left Main Interventions B123
